Literature DB >> 10793996

Telemedicine in the control of intra-ocular pressure.

G Michelson1, W Striebel, W Prihoda, V Schmidt.   

Abstract

Glaucoma is one of the most common causes of blindness in the Western world and a major risk factor is increased intra-ocular pressure. We therefore used telemedicine in its control. Patients measured their intra-ocular pressure several times a day with a portable instrument and the values were then entered into a portable digital assistant. These data were transmitted by a modem to a central server. If the intra-ocular pressure was pathologically high, an email message was automatically sent to the ophthalmologist. The pressure curve, including a statistical analysis, was displayed in an easily readable chart format. Ten patients with glaucoma participated in a trial. Self-tonometry with telemedicine enabled continuous evaluation of the patient by the ophthalmologist. This approach offered the advantage of controlling the treatment remotely. Advantages for the patient were that the measurements were easily done at home under normal conditions, and the patient could control when the measurement and data transmission would be performed. Telemedicine is a cost-effective technique enabling the early diagnosis of pathologically increased intra-ocular pressure.

Entities:  

Mesh:

Year:  2000        PMID: 10793996     DOI: 10.1258/1357633001934410

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

1.  [Telematic-assisted self-tonometry (TAS)].

Authors:  R Lämmer; M E M Groh; G Michelson
Journal:  Ophthalmologe       Date:  2004-08       Impact factor: 1.059

Review 2.  Thyroid cancer: possible role of telemedicine.

Authors:  G Gibelli; B Gibelli; F Nani
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-12       Impact factor: 2.124

3.  The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis.

Authors:  Sera-Melisa Thomas; Maya M Jeyaraman; Maya Jeyaraman; William G Hodge; Cindy Hutnik; John Costella; Monali S Malvankar-Mehta
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.